BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27460601)

  • 1. Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome.
    Filgueira CS; Nicolov E; Hood RL; Ballerini A; Garcia-Huidobro J; Lin JZ; Fraga D; Webb P; Sabek OM; Gaber AO; Phillips KJ; Grattoni A
    Int J Obes (Lond); 2016 Nov; 40(11):1776-1783. PubMed ID: 27460601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacokinetic study of GC-1 delivery using a nanochannel membrane device.
    Filgueira CS; Ballerini A; Nicolov E; Chua CYX; Jain P; Smith ZW; Gilbert AL; Scaglione F; Grattoni A
    Nanomedicine; 2017 Jul; 13(5):1739-1744. PubMed ID: 28259802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TRbeta-selective agonist confers resistance to diet-induced obesity.
    Amorim BS; Ueta CB; Freitas BC; Nassif RJ; Gouveia CH; Christoffolete MA; Moriscot AS; Lancelloti CL; Llimona F; Barbeiro HV; de Souza HP; Catanozi S; Passarelli M; Aoki MS; Bianco AC; Ribeiro MO
    J Endocrinol; 2009 Nov; 203(2):291-9. PubMed ID: 19713219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.
    Johansson L; Rudling M; Scanlan TS; Lundåsen T; Webb P; Baxter J; Angelin B; Parini P
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10297-302. PubMed ID: 16006512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired metabolic effects of a thyroid hormone receptor beta-selective agonist in a mouse model of diet-induced obesity.
    Castillo M; Freitas BC; Rosene ML; Drigo RA; Grozovsky R; Maciel RM; Patti ME; Ribeiro MO; Bianco AC
    Thyroid; 2010 May; 20(5):545-53. PubMed ID: 20406106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists: importance of liver selectivity in drug discovery.
    Takahashi N; Asano Y; Maeda K; Watanabe N
    Biol Pharm Bull; 2014; 37(7):1103-8. PubMed ID: 24989002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thyroid receptor β modulator GC-1 reduces atherosclerosis in ApoE deficient mice.
    Kannisto K; Rehnmark S; Slätis K; Webb P; Larsson L; Gåfvels M; Eggertsen G; Parini P
    Atherosclerosis; 2014 Dec; 237(2):544-54. PubMed ID: 25463087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats.
    Villicev CM; Freitas FR; Aoki MS; Taffarel C; Scanlan TS; Moriscot AS; Ribeiro MO; Bianco AC; Gouveia CH
    J Endocrinol; 2007 Apr; 193(1):21-9. PubMed ID: 17400799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas.
    Columbano A; Pibiri M; Deidda M; Cossu C; Scanlan TS; Chiellini G; Muntoni S; Ledda-Columbano GM
    Endocrinology; 2006 Jul; 147(7):3211-8. PubMed ID: 16574785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sustained delivery of GC-1 from a Nanofluidic system in a spontaneously obese non-human primate: a case study.
    Filgueira CS; Bruno G; Smith ZW; Chua CYX; Ballerini A; Folci M; Gilbert AL; Jain P; Sastry JK; Nehete PN; Shelton KA; Hill LR; Ali A; Youker KA; Grattoni A
    Biomed Microdevices; 2018 Jun; 20(2):49. PubMed ID: 29916059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronine.
    Grover GJ; Egan DM; Sleph PG; Beehler BC; Chiellini G; Nguyen NH; Baxter JD; Scanlan TS
    Endocrinology; 2004 Apr; 145(4):1656-61. PubMed ID: 14701670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia.
    Lee JH; Bullen JW; Stoyneva VL; Mantzoros CS
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E625-32. PubMed ID: 15522996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.
    Bryzgalova G; Effendic S; Khan A; Rehnmark S; Barbounis P; Boulet J; Dong G; Singh R; Shapses S; Malm J; Webb P; Baxter JD; Grover GJ
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):262-7. PubMed ID: 18621127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The T3 receptor beta1 isoform regulates UCP1 and D2 deiodinase in rat brown adipocytes.
    Martinez de Mena R; Scanlan TS; Obregon MJ
    Endocrinology; 2010 Oct; 151(10):5074-83. PubMed ID: 20719854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
    Luong XG; Stevens SK; Jekle A; Lin TI; Gupta K; Misner D; Chanda S; Mukherjee S; Williams C; Stoycheva A; Blatt LM; Beigelman LN; Symons JA; Raboisson P; McGowan D; Vandyck K; Deval J
    PLoS One; 2020; 15(12):e0240338. PubMed ID: 33306682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid Hormone Receptor β Agonist Induces β-Catenin-Dependent Hepatocyte Proliferation in Mice: Implications in Hepatic Regeneration.
    Alvarado TF; Puliga E; Preziosi M; Poddar M; Singh S; Columbano A; Nejak-Bowen K; Monga SP
    Gene Expr; 2016; 17(1):19-34. PubMed ID: 27226410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects and mechanisms of auricular vagus nerve stimulation on high-fat-diet--induced obese rats.
    Li H; Zhang JB; Xu C; Tang QQ; Shen WX; Zhou JZ; Chen JD; Wang YP
    Nutrition; 2015; 31(11-12):1416-22. PubMed ID: 26429664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity.
    Trost SU; Swanson E; Gloss B; Wang-Iverson DB; Zhang H; Volodarsky T; Grover GJ; Baxter JD; Chiellini G; Scanlan TS; Dillmann WH
    Endocrinology; 2000 Sep; 141(9):3057-64. PubMed ID: 10965874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sobetirome: a case history of bench-to-clinic drug discovery and development.
    Scanlan TS
    Heart Fail Rev; 2010 Mar; 15(2):177-82. PubMed ID: 19002578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone acting via TRβ induces expression of browning genes in mouse bone marrow adipose tissue.
    Lindsey RC; Mohan S
    Endocrine; 2017 Apr; 56(1):109-120. PubMed ID: 28229360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.